ADM Tronics Unlimited, Inc. (ADMT) stock
ADMTOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends March 31
$0.05−0.00 (-4.00%)
Close on Oct 19, 2026Market cap $3.24MP/E –Yield –
ADM Tronics Unlimited r&d expenses
Research and development expenses are spending on new products and technology.
ADM Tronics Unlimited's R&D Expenses for the twelve months ending Jun 30, 2026 was $522.65K, up 1.5% year over year. For fiscal 2026 it was $544.97K, up 5.4% from the year before. Over ten years it grew 19.5% a year on average. The highest annual figure on record is $673.86K in fiscal 2019.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $544.97K | +5.4% |
| FY2025 | Mar 31, 2025 | $517.28K | -10.3% |
| FY2024 | Mar 31, 2024 | $576.90K | +6.6% |
| FY2023 | Mar 31, 2023 | $541.18K | -12.1% |
| FY2022 | Mar 31, 2022 | $615.93K | -6.1% |
| FY2021 | Mar 31, 2021 | $655.96K | +11.3% |
| FY2020 | Mar 31, 2020 | $589.37K | -12.5% |
| FY2019 | Mar 31, 2019 | $673.86K | +27.7% |
| FY2018 | Mar 31, 2018 | $527.66K | +212.6% |
| FY2017 | Mar 31, 2017 | $168.81K | +83.9% |
| FY2016 | Mar 31, 2016 | $91.77K | +141.2% |
| FY2015 | Mar 31, 2015 | $38.06K | +9.2% |
| FY2014 | Mar 31, 2014 | $34.86K | +1.8% |
| FY2013 | Mar 31, 2013 | $34.25K | -4.5% |
| FY2012 | Mar 31, 2012 | $35.86K | -17.2% |
| FY2011 | Mar 31, 2011 | $43.29K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $103.27K | -17.8% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $142.43K | +22.1% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $180.21K | +11.9% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $96.74K | -13.3% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $125.59K | -1.9% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $116.69K | -14.9% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $161.01K | +23.3% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $111.59K | -21.0% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $127.99K | +3.6% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $137.07K | -2.5% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $130.59K | -27.9% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $141.29K | +6.4% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $123.60K | -23.4% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $140.56K | -41.3% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $181.22K | +10.4% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $132.77K | +5.0% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $161.37K | +28.2% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $239.44K | +91.2% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $164.11K | -3.3% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $126.51K | -15.0% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $125.90K | -13.6% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $125.21K | -63.4% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $169.65K | +47.3% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $148.75K | +39.4% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $145.77K | +32.7% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $342.07K | +164.5% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $115.20K | +5.5% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $106.72K | -23.4% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $109.87K | -26.7% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $129.31K | +649.0% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $109.17K | -4.0% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $139.23K | +700.4% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $149.96K | +635.0% |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $17.26K | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $113.75K | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $17.40K | – |
| Q1 FY2017CQ2 2016 | Jun 30, 2016 | $20.40K | – |
See a number that looks wrong?